High Times
Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

Along this line of reasoning (Earlier Exchange) Don’t sweat the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
slcimmuno Member Profile
 
Followed By 74
Posts 1,483
Boards Moderated 0
Alias Born 06/06/12
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2018 4:17:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/15/2018 6:20:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/10/2018 10:56:48 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/9/2018 6:54:26 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/9/2018 6:53:37 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/24/2018 4:36:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/24/2018 4:33:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/21/2018 4:03:40 PM
Annual Report (10-k) Edgar (US Regulatory) - 9/11/2018 4:04:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/29/2018 2:11:50 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/29/2018 7:24:52 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2018 4:14:20 PM
Traders News Issues Research on High Growth Canna and Pharma Stocks InvestorsHub NewsWire - 4/25/2018 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/16/2018 1:18:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2018 3:04:31 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/7/2018 4:59:15 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/11/2018 4:35:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/27/2017 3:08:40 PM
Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) Edgar (US Regulatory) - 11/13/2017 10:03:05 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2017 4:04:57 PM
slcimmuno   Friday, 01/12/18 06:44:46 PM
Re: PlentyParanoid post# 212618
Post # of 245697 
Along this line of reasoning
(Earlier Exchange)

Don’t sweat the P value too much when it’s early - esp for a condition like OM w next-to-nil viable treatments


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136803687

Some common misperceptions about p-values

"For a certain Phase II clinical trial, where the safety and efficacy of a new treatment is still being explored, one can argue for a more liberal alpha to give the treatment a higher level of the benefit of doubt, especially when the disease or condition have only a few, if any, effective treatment options. If it should pass, it would be weeded out in a Phase III trial with a more stringent significance level."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245357/


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist